These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

107 related items for PubMed ID: 1940587

  • 41. [Wilson's disease].
    Kovacević I, Zekan M.
    Acta Med Croatica; 2003; 57(3):227-35. PubMed ID: 14582469
    [Abstract] [Full Text] [Related]

  • 42. Liver transplantation for Wilson's disease.
    Sevmis S, Karakayali H, Aliosmanoglu I, Yilmaz U, Ozcay F, Torgay A, Arslan G, Haberal M.
    Transplant Proc; 2008; 40(1):228-30. PubMed ID: 18261593
    [Abstract] [Full Text] [Related]

  • 43. Iron accumulation in the liver of male patients with Wilson's disease.
    Shiono Y, Wakusawa S, Hayashi H, Takikawa T, Yano M, Okada T, Mabuchi H, Kono S, Miyajima H.
    Am J Gastroenterol; 2001 Nov; 96(11):3147-51. PubMed ID: 11721763
    [Abstract] [Full Text] [Related]

  • 44. Withdrawal of penicillamine from zinc sulphate-penicillamine maintenance therapy in Wilson's disease: promising, safe and cheap.
    Sinha S, Taly AB.
    J Neurol Sci; 2008 Jan 15; 264(1-2):129-32. PubMed ID: 17765927
    [Abstract] [Full Text] [Related]

  • 45. Resolution of decompensated cirrhosis from Wilson's disease with zinc monotherapy: a potential therapeutic option?
    Lee VD, Northup PG, Berg CL.
    Clin Gastroenterol Hepatol; 2006 Aug 15; 4(8):1069-71. PubMed ID: 16793346
    [Abstract] [Full Text] [Related]

  • 46. [Effect of oral ZnSO4 on urine copper and blood trace elements in 60 patients with Wilson's disease].
    Yang RM.
    Zhonghua Yi Xue Za Zhi; 1986 Apr 15; 66(4):211-3, 254. PubMed ID: 3094875
    [No Abstract] [Full Text] [Related]

  • 47. The mechanisms of penicillamine, trientine, and zinc in the treatment of Wilson's disease.
    Yarze JC.
    Am J Gastroenterol; 1995 Jun 15; 90(6):1026. PubMed ID: 7771405
    [No Abstract] [Full Text] [Related]

  • 48. Results of treatment of Wilson's disease--own observations.
    Jabłońska-Kaszewska I, Drobińska-Jurowiecka A, Dabrowska E, Trocha H.
    Med Sci Monit; 2003 Aug 15; 9 Suppl 3():9-14. PubMed ID: 15156603
    [Abstract] [Full Text] [Related]

  • 49. Evaluation of the Unified Wilson's Disease Rating Scale (UWDRS) in German patients with treated Wilson's disease.
    Leinweber B, Möller JC, Scherag A, Reuner U, Günther P, Lang CJ, Schmidt HH, Schrader C, Bandmann O, Czlonkowska A, Oertel WH, Hefter H.
    Mov Disord; 2008 Jan 15; 23(1):54-62. PubMed ID: 17960799
    [Abstract] [Full Text] [Related]

  • 50. [Occurrence of copper metabolism abnormalities in the families of four individuals with newly diagnosed Wilson's disease].
    Dastych M.
    Vnitr Lek; 1997 Feb 15; 43(2):87-90. PubMed ID: 9245074
    [Abstract] [Full Text] [Related]

  • 51. Using zinc to remove copper from pediatric patients with Wilson's disease.
    Klevay LM.
    J Lab Clin Med; 2001 Sep 15; 138(3):214. PubMed ID: 11548740
    [No Abstract] [Full Text] [Related]

  • 52. Oral zinc therapy normalizes serum uric acid level in Wilson's disease patients.
    Umeki S, Ohga R, Konishi Y, Yasuda T, Morimoto K, Terao A.
    Am J Med Sci; 1986 Nov 15; 292(5):289-92. PubMed ID: 3777013
    [Abstract] [Full Text] [Related]

  • 53. Management of Wilson's disease with zinc sulphate. Experience in a series of 27 patients.
    Hoogenraad TU, Van Hattum J, Van den Hamer CJ.
    J Neurol Sci; 1987 Feb 15; 77(2-3):137-46. PubMed ID: 3819764
    [Abstract] [Full Text] [Related]

  • 54. The level of serum lipids, vitamin E and low density lipoprotein oxidation in Wilson's disease patients.
    Rodo M, Czonkowska A, Pulawska M, Swiderska M, Tarnacka B, Wehr H.
    Eur J Neurol; 2000 Sep 15; 7(5):491-4. PubMed ID: 11054132
    [Abstract] [Full Text] [Related]

  • 55. [Application of zinc agents in Wilson's disease].
    Liang C, Hou W, Duan ZP, Zheng SJ.
    Zhonghua Gan Zang Bing Za Zhi; 2024 Sep 20; 32(9):850-853. PubMed ID: 39375107
    [Abstract] [Full Text] [Related]

  • 56. Zinc treatment of Wilson's disease.
    Brewer GJ, Hill GM, Prasad AS, Rabbani P.
    Ann Intern Med; 1984 Jul 20; 101(1):144-5. PubMed ID: 6732083
    [No Abstract] [Full Text] [Related]

  • 57. Treatment of Wilson's disease with zinc.
    Brewer GJ.
    J Lab Clin Med; 1999 Sep 20; 134(3):322-4. PubMed ID: 10482318
    [No Abstract] [Full Text] [Related]

  • 58. Copper Deficiency in Wilson's Disease with a Normal Zinc Value.
    Ueda M, Katsuse K, Kakumoto T, Kobayashi S, Ishiura H, Mitsui J, Toda T.
    Intern Med; 2023 Apr 01; 62(7):1073-1076. PubMed ID: 36047117
    [Abstract] [Full Text] [Related]

  • 59. [Cholesterol esterification catalysed by LCAT and erythrocyte lipid pattern in Wilson's disease].
    Wehr H, Gorska D, Wisniewska D, Czlonkowska A, Rodo M.
    Pol Tyg Lek; 1977 Apr 11; 32(15):549-51. PubMed ID: 859765
    [No Abstract] [Full Text] [Related]

  • 60. Fatal deterioration of Wilson's disease after institution of oral zinc therapy.
    Lang CJ, Rabas-Kolominsky P, Engelhardt A, Kobras G, Konig HJ.
    Arch Neurol; 1993 Oct 11; 50(10):1007-8. PubMed ID: 8280286
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.